Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.00 (+1.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Capital Expenditures (2022 - 2026)

Updated

Context Therapeutics' Capital Expenditures was $18,488 in Q2 2026, down 50.4% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Capital Expenditures (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Context Therapeutics' Capital Expenditures was $55,746 through Jun 30, 2026, up 35.1% year-over-year; for FY2025, it came in at $33,948, up 364.0% from FY2024.

  • Capital Expenditures shows a three-year compound annual growth rate of -2.7% (FY2022 to FY2025).
  • In earlier years, Capital Expenditures was $7,316 in FY2024 and $36,836 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Capital Expenditures since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 322.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 140.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 533.00 Mn
10 Context Therapeutics 21.97 Mn -218.49 Mn - 18,488.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18,488.00
Mar 31, 2026 37,258.00
Mar 31, 2025 33,948.00
Sep 30, 2024 7,316.00
Jun 30, 2022 1,837.00
Mar 31, 2022 34,999.00
API Access

Context Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CNTX&period=max&api_key=YOUR_API_KEY